The potential role of N7-methylguanosine (m7G) in cancer
Y Luo, Y Yao, P Wu, X Zi, N Sun, J He - Journal of hematology & oncology, 2022 - Springer
Abstract N 7-methylguanosine (m7G), one of the most prevalent RNA modifications, has
recently attracted significant attention. The m7G modification actively participates in …
recently attracted significant attention. The m7G modification actively participates in …
[HTML][HTML] Blood-based DNA methylation signatures in cancer: A systematic review
Y Li, Z Fan, Y Meng, S Liu, H Zhan - … Acta (BBA)-Molecular Basis of Disease, 2023 - Elsevier
DNA methylation profiles are in dynamic equilibrium via the initiation of methylation,
maintenance of methylation and demethylation, which control gene expression and …
maintenance of methylation and demethylation, which control gene expression and …
Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer
MV García-Ortiz, P Cano-Ramírez… - Clinical …, 2023 - Springer
Background Pancreatic cancer is the most lethal cancer with a dismal prognosis mainly due
to diagnosis at advanced stage and ineffective treatments. CA19-9 levels and computed …
to diagnosis at advanced stage and ineffective treatments. CA19-9 levels and computed …
Resistance to gemcitabine in pancreatic ductal adenocarcinoma: A physiopathologic and pharmacologic review
T Koltai, SJ Reshkin, TMA Carvalho, D Di Molfetta… - Cancers, 2022 - mdpi.com
Simple Summary PDAC is one of the most malignant tumors and its treatment, whether
surgery or chemotherapy, has shown poor results. Resistance to gemcitabine and other …
surgery or chemotherapy, has shown poor results. Resistance to gemcitabine and other …
[HTML][HTML] WBSCR22 and TRMT112 synergistically suppress cell proliferation, invasion and tumorigenesis in pancreatic cancer via transcriptional regulation of ISG15
AA Khan, H Huang, Y Zhao, H Li… - International …, 2022 - spandidos-publications.com
Pancreatic cancer (PC) is one of the most aggressive and devastating types of cancer owing
to its poor prognosis and deadly characteristics. It is well established that aberrations in the …
to its poor prognosis and deadly characteristics. It is well established that aberrations in the …
Obesity associated pancreatic ductal adenocarcinoma: Therapeutic challenges
M Srilatha, R Malla, MP Adem, JB Foote… - Seminars in Cancer …, 2023 - Elsevier
Obesity is a prominent health issue worldwide and directly impacts pancreatic health, with
obese individuals exhibiting a significant risk for increasing pancreatic ductal …
obese individuals exhibiting a significant risk for increasing pancreatic ductal …
[HTML][HTML] FcRn expression in cancer: Mechanistic basis and therapeutic opportunities
I Rudnik-Jansen, KA Howard - Journal of Controlled Release, 2021 - Elsevier
There is an urgent need to identify new cellular targets to expand the repertoire, potency and
safety of cancer therapeutics. Neonatal Fc Receptor (FcRn)-driven cellular recycling plays a …
safety of cancer therapeutics. Neonatal Fc Receptor (FcRn)-driven cellular recycling plays a …
Anticancer mechanisms of phytochemical compounds: focusing on epigenetic targets
N El Omari, M Bakha, H Imtara… - … Science and Pollution …, 2021 - Springer
It has recently been proven that epigenetic dysregulation is importantly involved in cell
transformation and therefore induces cancerous diseases. The development of molecules …
transformation and therefore induces cancerous diseases. The development of molecules …
[HTML][HTML] MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications
LA Bravo-Vázquez, N Frías-Reid… - Translational …, 2023 - Elsevier
MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are two relevant classes of non-
coding RNAs (ncRNAs) that play a pivotal role in a number of molecular processes through …
coding RNAs (ncRNAs) that play a pivotal role in a number of molecular processes through …
[HTML][HTML] Targeting pancreatic cancer immune evasion by inhibiting histone deacetylases
The immune system plays a vital role in maintaining the delicate balance between immune
recognition and tumor development. Regardless, it is not uncommon that cancerous cells …
recognition and tumor development. Regardless, it is not uncommon that cancerous cells …